Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial Academic Article Article uri icon

Overview

MeSH Major

  • Amyotrophic Lateral Sclerosis
  • Biomarkers
  • Muscle Weakness
  • Nerve Growth Factors
  • Neuropeptides

abstract

  • Exelixis, National Institutes of Health and National Cancer Institute Cancer Center Support Grant P30 CA008748.

publication date

  • December 2016

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(16)30562-9

PubMed ID

  • 27825636

Additional Document Info

start page

  • 1653

end page

  • 1660

volume

  • 17

number

  • 12